Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation
Authors:
- Iraklis C. KourtisIKIraklis C. Kourtis
- André J. van der VliesAVAndré J. van der Vlies
- Jeffrey A. HubbellJHJeffrey A. Hubbell
- Melody A. SwartzMSMelody A. Swartz
- 1 November 2010
- Vol. 28 (50) , 7897-7906
Abstract
No abstract availableKeywords
Funding Information
- Swiss Competence Center in Materials Science
- Swiss Vaccine Research Institute
- Bill and Melinda Gates Foundation
- European Research Commission
- Merck-Serono
This publication has 48 references indexed in Scilit:
- Tumor Delivery and In Vivo Processing of Disulfide-Linked and Thioether-Linked Antibody−Maytansinoid ConjugatesBioconjugate Chemistry, 2009
- Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentationProceedings of the National Academy of Sciences, 2009
- Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune responseJournal of Drug Targeting, 2009
- MHC class II molecules on the move for successful antigen presentationThe EMBO Journal, 2007
- Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimerNature Immunology, 2007
- Dynasore, a Cell-Permeable Inhibitor of DynaminDevelopmental Cell, 2006
- In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticlesJournal of Controlled Release, 2006
- Post-proteasomal antigen processing for major histocompatibility complex class I presentationNature Immunology, 2004
- In Vivo Cross-Priming of MHC Class I–Restricted Antigens Requires the TAP TransporterImmunity, 1996
- THE DETAILED DISTRIBUTION OF HLA-A, B, C ANTIGENS IN NORMAL HUMAN ORGANSTransplantation, 1984